The global angioedema market is expected to register a steady revenue CAGR during the forecast period owing to its prevalence rate. According to the National Institute of Health (NIH), hereditary angioedema and acquired angioedema account for around 1% to 2% of angioedema cases, with hereditary angioedema being 10 times more common than acquired angioedema. It affects one out of every 100,000 to 500,000 people. Increased public and government initiatives, such as the government increasing funding for orphan drugs, increased demand for targeted therapies, and pharmaceutical drug manufacturers are focusing on developing novel therapeutics for angioedema in order to meet the large unmet medical needs, which are expected to drive revenue growth of the market over the forecast period.

Angioedema is a rare disease that causes non-pitting swelling of certain body areas, such as the skin and mucous membranes. It is usually not significant, but for some people, it can be a recurring condition, and it can be life-threatening if it compromises breathing. Swelling may usually be kept under control with treatment. Angioedema most usually affects the hands, feet, area around the eye, lips, tongue, and genitals. Angioedema can also cause respiratory problems in more serious situations. On the basis of causes, angioedema can be classified into hereditary angioedema and acquired angioedema.

An analysis of Angioedema's growth rate, market share, market size, current and emerging trends, production and consumption ratios, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players is provided in the report, which has been segmented into key regions globally. This report provides a country-by-country analysis of the Angioedema market to give a clearer picture of its regional distribution and growth.

Request a sample report of Angioedema Market @ https://www.reportsanddata.com/download-free-sample/5272

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are

• ActiveSite pharmaceuticals
• CSL Behring
• Takeda pharmaceutical
• Biocryst
• Astria Therapeutics, Inc. 
• Adverum Biotechnologies, Inc.
• Ionis Pharmaceuticals
• Attune Pharmaceuticals
• Sanofi
• Merck Co., Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Company
• Novartis AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Abbott Laboratories
• Cycle Pharmaceuticals

Product Type Outlook (Revenue, USD Billion; 2019-2030)

• Solid Dosage form
  • Tablets
  • Capsules
• Liquid dosage form
  • Injectables

Route of Administration Outlook (Revenue, USD Billion; 20219-2030)

• Parenteral route
• Subcutaneous
• Intravenous
• Oral route

Disease Indication Outlook (Revenue, USD Billion; 2019-2030)

• Acquired Angioedema
• Idiopathic Angioedema
• Allergic Angioedema
• Drug-Induced Angioedema
• Hereditary Angioedema

Therapy Outlook (Revenue, USD Billion; 2019-2030)

• Idiopathic angioedema drug class
• Antihistamine
• Corticosteroids
• Glucocorticoids
• Adrenaline injection
• Hereditary angioedema drug class
• C1 Esterase Inhibitor
• Selective Bradykinin B2 Receptor Antagonist
• Kallikrein Inhibitor

Read the full report @ https://www.reportsanddata.com/report-detail/angioedema-market

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East Africa

Major Points covered in this report are as below:

• An analysis of Angioedema industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.

• In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.

• In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.

• This report provides information on the market status of Angioedema manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/5272

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Browse More Reports:

Video-Guided Pericardial Access Device Market @ https://www.reportsanddata.com/report-detail/video-guided-pericardial-access-device-market

Simethicone Oral Liquid Market @ https://www.reportsanddata.com/report-detail/simethicone-oral-liquid-market

Digital Biology Market @ https://www.reportsanddata.com/report-detail/digital-biology-market

Injectable Sumatriptan Market @ https://www.reportsanddata.com/report-detail/injectable-sumatriptan-market

Dental 3D Printing Market @ https://www.reportsanddata.com/report-detail/dental-3d-printing-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report